Alzheimer's genetic mutation discovered by HKUST generates fresh hope

Scientists at the Hong Kong University of Science and Technology (HKUST) have pinpointed a rare genetic mutation called TREM2 H157Y that sharply raises the odds of Alzheimer's disease among Chinese individuals, quickening the speed mental deterioration from six to eight years to just three to five. The identification of this mutation offers fresh hope for targeted treatments in this fast-aging population.

This groundbreaking research marks the first deep dive into family histories and clinical cases of the variant, which shows up in roughly one out of every 200 Chinese patients with Alzheimer's. 

The mutation not only heightens vulnerability to the brain-wasting condition but also triggers a more aggressive cascade of neurodegeneration, leaving carriers to grapple with rapid memory loss, confusion, and physical impairments far sooner than those without it. 

At the helm of the effort was HKUST's president Nancy Chu Ip Yuk-yu, who stated that such tailored insights could pave the way for customized care plans, like earlier interventions or lifestyle tweaks suited to at-risk families, while arming drug developers with clues to craft therapies that hit the variant head-on.

The Hong Kong Center for Neurodegenerative Diseases created a biobank for the research into Alzheimer's.

This repository gathers clinical records, brain scans, and advanced biological data from Chinese participants, making it an invaluable hub for unearthing population-specific risks.